
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current EMITF market cap is 19.3M. The company's latest EPS is ILS -1.9740 and P/E is -1.06.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | |
Total Revenue | 3.32M | 0 | 811k | 590k | 328k |
Operating Income | -96.45M | -10.69M | -18.03M | -3.32M | -4.26M |
Net Income | -107.5M | 229.85M | -20.5M | -311k | -18.14M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | |
Total Assets | 150.25M | 102.01M | 72.27M | 64.01M | 63.79M |
Total Liabilities | 319.49M | 7.56M | 1.35M | 1.35M | 1.12M |
Total Equity | -169.24M | 94.45M | 70.92M | 62.66M | 62.67M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | |
Operating | -14.8M | -15.65M | -3.38M | -3.44M | -2.95M |
Investing | 17M | 126.96M | 23.58M | 23.89M | 4.7M |
Financing | -22.98M | -143.22M | -2.8M | -10.07M | 8M |
Market Cap | 19.3M |
Price to Earnings Ratio | -1.06 |
Price to Sales Ratio | 58.82 |
Price to Cash Ratio | 0.51 |
Price to Book Ratio | 0.31 |
Dividend Yield | - |
Shares Outstanding | 9.19M |
Average Volume (1 week) | 1.46k |
Average Volume (1 Month) | 2.44k |
52 Week Change | 110.00% |
52 Week High | 2.32 |
52 Week Low | 0.80 |
Spread (Intraday) | 0 (0%) |
Company Name | Elbit Imaging Ltd (CE) |
Address |
7 mota gur, olympia c tower petah tikva, center 4952801 |
Website | https://www.elbitimaging.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions